If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSomero Regulatory News (SOM)

Share Price Information for Somero (SOM)

Share Price is delayed by 15 minutes
Get Live Data
187.50    -2.50 (-1.33%)
Bid:
185.00
Ask:
190.00
Spread: 5.00 (2.703%)
Market Cap: £95.79m
SOM Live PriceLast checked at - London Stock Exchange

Intraday Somero Share Chart

Trading Update

24 Jul 2023 07:00

RNS Number : 8395G
Somero Enterprises Inc.
24 July 2023
 

24 July 2023

Somero Enterprises, Inc.

("Somero", "the Company" or "the Group")

 

Trading Update

Somero® provides an update on trading for the six months to 30 June 2023 ahead of its interim results announcement, scheduled for release on 31 August 2023.

With non-residential construction and underlying market conditions remaining healthy across the Company's major markets and following a solid June, trading for H1 2023 ended at the high end of the guidance range set forth in the 20 June 2023 trading update.

 

As expected, trading in North America was the driver for the overall decline compared to H1 2022, due to the factors previously reported in the 20 June 2023 trading update, while H1 2023 trading in Europe and Australia reflected the positive momentum carried forward from H2 2022 with both regions reporting improvement over the comparable H1 2022 result. Performance in the European and Australian markets, supported by healthy market activity, has been driven by strategic investments in both regions and traction with acquiring new customer relationships and with increased market penetration of our broader product offering. Territories comprising our Rest of World regions contributed positively to H1 2023 trading on a combined basis as expected, driven in part by Latin America and the Middle East that both reported increased revenues compared to H1 2022.

 

Also as indicated in our 20 June 2023 trading update, the Company anticipates improvement in H2 2023 trading in North America compared to H1 2023 driven by increased availability of the S-22EZ, supported by direct feedback from customers indicating healthy non-residential construction activity across a wide range of project types that translates to extended project backlogs. The Company also anticipates healthy contributions to H2 2023 trading from Europe and Australia, and H2 2023 trading comparable to H1 2023 in the Rest of World territories. 

 

As such, the Board remains confident that 2023 results will fall in line with market expectations with revenues of approximately US$ 120m, EBITDA of approximately US$ 36m, and year-end cash of approximately US$ 32m.

 

 

Enquiries:

 

 

 

Somero Enterprises, Inc.

www.somero.com

Jack Cooney, CEO

+1 239 210 6500

John Yuncza, President

 

Vincenzo LiCausi, CFO

 

Howard Hohmann, EVP Sales

 

 

 

finnCap Ltd (NOMAD and Broker)

+44 (0)20 7220 0500

Matt Goode/Seamus Fricker/Fergus Sullivan (Corporate Finance)

 

Tim Redfern/Harriet Ward (ECM)

 

 

 

Alma PR (Financial PR Advisor)

somero@almapr.co.uk

David Ison

+44 (0)20 3405 0205

Rebecca Sanders-Hewett

Pippa Crabtree

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKDBBDBKDPOB
Date   Source Headline
12th Mar 201012:27 pmRNSDirector/PDMR Shareholding
25th Feb 20106:05 pmRNSDirector/PDMR Shareholding
8th Feb 20107:00 amRNSTrading Statement
23rd Nov 20097:00 amRNSTrading update
15th Oct 20094:42 pmRNSDirectorate Change
15th Sep 20097:00 amRNSInterim Results
7th Jul 20094:59 pmRNSHolding(s) in Company
1st Jul 20094:07 pmRNSHolding(s) in Company
30th Jun 20094:04 pmRNSHolding(s) in Company
29th Jun 20092:41 pmRNSHolding(s) in Company
26th Jun 20095:11 pmRNSHolding(s) in Company
24th Jun 200912:04 pmRNSHolding(s) in Company
24th Jun 20097:00 amRNSPlacing announcement
18th Jun 200912:22 pmRNSResult of AGM
15th Jun 20095:53 pmRNSAnnual Report and Notice of AGM
4th Jun 200911:20 amRNSHolding(s) in Company
7th May 20095:35 pmRNSHolding(s) in Company
6th May 20097:00 amRNSFinal Results
30th Jan 20095:55 pmRNSNotification of Major Interests in Shares
28th Jan 20094:08 pmRNSHolding(s) in Company
28th Jan 20094:08 pmRNSHolding(s) in Company
27th Jan 20097:00 amRNSTrading Statement
16th Jan 20097:45 amRNSNotification of Major Interests in Shares
18th Nov 20085:14 pmRNSHolding(s) in Company
12th Nov 20084:32 pmRNSHolding(s) in Company
4th Nov 20087:00 amRNSTrading Statement
1st Oct 20083:11 pmRNSHolding(s) in Company
23rd Sep 20084:58 pmRNSHolding(s) in Company
9th Sep 20087:00 amRNSInterim Results
14th Jul 20087:00 amRNSTrading Update
5th Jun 200811:33 amRNSResult of AGM
20th May 20087:00 amRNSHolding(s) in Company
15th May 20087:00 amRNSTrading Statement
8th May 20087:01 amRNSNotice of AGM - Replacement
6th May 20087:02 amRNSNotice of AGM
7th Apr 20087:00 amRNSHolding(s) in Company
1st Apr 20087:01 amRNSFinal Results
13th Mar 20083:31 pmRNSNotice of Results
29th Feb 20087:01 amRNSCREST Admission
1st Feb 20084:54 pmRNSHolding(s) in Company
17th Jan 20084:52 pmRNSHolding(s) in Company
10th Jan 20087:01 amRNSPeriod End Trading Update
20th Dec 20076:13 pmRNSDirector/PDMR Shareholding
22nd Nov 20073:13 pmRNSHolding(s) in Company
21st Nov 20077:01 amRNSOffice Openings
14th Nov 20073:48 pmRNSHolding(s) in Company
13th Sep 20077:01 amRNSAnalyst & Investor Site Visit
6th Sep 20077:01 amRNSInterim Results
17th Aug 20073:20 pmRNSNotice of Results
16th Aug 20075:10 pmRNSAIM Rule 26 - Company Website

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.